SCHEMBL31728370

SCHEMBL31728370

CC(Oc1cnc(Cl)c2ncnc(N)c12)c1ncn(C(F)F)n1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31729284 0.82 SRC (0.37) SRC
SCHEMBL31727755 0.82 SRC (0.34) SRC
SCHEMBL31729203 0.82 SRC (0.41) SRC
SCHEMBL31727977 0.81 PIK3CD (0.31) SRC
SCHEMBL31728587 0.80 SRC (0.31) SRC
SCHEMBL31728375 0.79 — —
SCHEMBL31728243 0.79 MET (0.34) SRC
SCHEMBL31728138 0.78 JAK2 (0.33) SRC
SCHEMBL31727729 0.77 — —
SCHEMBL31728513 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
Send feedback